Stocks DAO Financial statements
Financial statementsYoudao, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Youdao, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 187 | 485 | 630 | 727 | 759 | 771 | 845 |
| Cost of revenue | 134 | 263 | 318 | 352 | 369 | 394 | 471 |
| Gross profit | 53.2 | 223 | 312 | 375 | 390 | 377 | 374 |
| Research and development | 39.6 | 65.1 | 95.3 | 117 | 105 | 74 | 73.5 |
| Selling and marketing | 89.5 | 413 | 326 | 338 | 320 | 257 | 241 |
| General and administrative | 10.5 | 21.2 | 29.9 | 33.2 | 31.3 | 25.6 | 28.2 |
| Operating expenses | 140 | 500 | 460 | 487 | 455 | 356 | 343 |
| Operating income | -86.3 | -277 | -148 | -112 | -65.7 | 20.4 | 31.6 |
| Interest expense | 4.78 | 4.97 | 6.61 | 9.79 | 10 | 9.01 | |
| Interest income | 3.91 | 2.95 | 1.87 | 1.18 | 0.54 | 0.35 | |
| Other non-operating income | 2.88 | 9.36 | 5.76 | 11.8 | -1.63 | 0.22 | -6.74 |
| Pre-tax income | -268 | -144 | -105 | -75.9 | 11.1 | 16.2 | |
| Income tax | 0.35 | 0.45 | 1.04 | 2.01 | 1.56 | 0.82 | 2.37 |
| Net income to minority interests | 0.01 | -0.09 | -4.82 | -2.73 | -0.03 | -0.96 | -1.47 |
| Net income | -86.4 | -269 | -156 | -105 | -77.5 | 11.3 | 15.4 |
| EBITDA | -84.8 | -274 | -143 | -106 | -61.5 | 24.4 | 35 |
| EPS, basic | -0.96 | -2.38 | -1.28 | -0.85 | -0.64 | 0.10 | 0.13 |
| EPS, diluted | -0.96 | -2.38 | -1.28 | -0.85 | -0.64 | 0.10 | 0.13 |
| Shares, basic (weighted) | 95.4 | 113 | 122 | 124 | 121 | 117 | 118 |
| Shares, diluted (weighted) | 95.4 | 113 | 122 | 124 | 121 | 118 | 120 |
Balance sheet
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 24.9 | 93.4 | 50.7 | 114 | 64 | 81.2 | 62.9 |
| Short-term investments | 17.4 | 89.7 | 79.1 | 33.7 | 10.1 | 8.64 | 42.7 |
| Receivables | 28.8 | 41.2 | 39 | 58.7 | 49.9 | 57.4 | 54.5 |
| Inventory | 10.5 | 22.8 | 40.1 | 33.7 | 30.6 | 23.9 | 20.1 |
| Other current assets | 17.4 | 36.1 | 28.7 | 30.1 | 24.7 | 21.1 | 19.9 |
| Total current assets | 292 | 284 | 356 | 271 | 183 | 204 | 246 |
| Property, plant and equipment | 3.53 | 6.99 | |||||
| Lease right-of-use assets | 3.43 | 16.2 | 18.5 | 11.4 | 12.5 | 9.38 | 6.71 |
| Goodwill | 17.3 | 15.9 | 15.5 | 15.1 | 15.7 | ||
| Long-term investments | 6.51 | 5.1 | 13.2 | 7.24 | 9.92 | 2.83 | |
| Other non-current assets | 1.17 | 3.79 | 3.52 | 5.08 | 6.34 | 4.12 | 4.47 |
| Total assets | 300 | 317 | 413 | 330 | 235 | 249 | 282 |
| Accounts payable | 9 | 21.7 | 25.3 | 40.9 | 22.4 | 19.9 | 15.7 |
| Accrued liabilities | 13.6 | 32.1 | 43.5 | 38.6 | 39.8 | 36.2 | 42.2 |
| Deferred revenue | 65.6 | 221 | 167 | 155 | 148 | 132 | 121 |
| Total current liabilities | 253 | 520 | 476 | 461 | 437 | 404 | 420 |
| Lease liabilities | 3.05 | 12.2 | 11.5 | 6.33 | 6.95 | 3.5 | 2.69 |
| Other non-current liabilities | 0.79 | 0.62 | 0.38 | 1.28 | 2.3 | 2.49 | 4.12 |
| Total liabilities | 256 | 533 | 528 | 544 | 535 | 535 | 559 |
| Paid-in capital | 321 | 354 | 614 | 579 | 568 | 554 | 580 |
| Treasury stock | -6.14 | -24.2 | -28.9 | -25.2 | |||
| Other comprehensive income | -7.21 | -8.53 | -13.4 | -14.2 | -15.3 | -14.3 | |
| Minority interests | 0.13 | 0.15 | -0.3 | -0.98 | 2.77 | 6.94 | 5.71 |
| Total equity | 43.2 | -216 | -127 | -224 | -305 | -286 | -277 |
| Total liabilities and equity | 300 | 317 | 413 | 330 | 235 | 249 | 282 |
| Shares outstanding | 112 | 115 | 123 | 123 | 119 | 118 | 119 |
Cash flow statement
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -86.4 | -269 | -161 | -108 | -77.5 | 10.3 | 13.9 |
| Depreciation and amortization | 1.52 | 2.47 | 4.72 | 6.12 | 4.18 | 3.97 | 3.35 |
| Stock-based compensation | 3.6 | 6.37 | 11.3 | 10.3 | 4.34 | 3.1 | 4.96 |
| Deferred income tax | -1.41 | ||||||
| Change in receivables | -17.5 | -12.3 | 3.9 | -23.7 | 6.2 | -9.38 | 2.91 |
| Change in inventory | -7.55 | -11.1 | -23 | 2.9 | 1.23 | 3.4 | 2.61 |
| Change in payables | 4.04 | 12.1 | 1.95 | 17.6 | -17.4 | -1.9 | -5.04 |
| Cash from operations | -53.5 | -49.3 | -211 | -87.4 | -61.7 | -9.3 | 7.89 |
| Capital expenditures | -2.61 | -5.65 | -9.96 | -9.95 | -2.51 | -1.62 | -3.66 |
| Acquisitions | -0.98 | 6.78 | -0.59 | ||||
| Purchases of investments | -31 | -258 | -122 | -182 | -15.5 | -3.43 | -48.2 |
| Cash from investing | -156 | 117 | 7.39 | 18.2 | 17.7 | -1.86 | -36.2 |
| Share buybacks | -7.35 | -18 | -8.54 | ||||
| Cash from financing | 228 | 4.07 | 280 | 26.8 | -2.67 | 31.3 | 6.53 |
| Net change in cash | 18.9 | 66.8 | 72.7 | -41.8 | -46.4 | 19.8 | -22.1 |
| Free cash flow | -56.1 | -54.9 | -221 | -97.4 | -64.2 | -10.9 | 4.23 |
| Interest paid | 4.28 | 4.38 | 4.48 | 5.71 | 8.92 | 12.9 | 8.86 |
| Income taxes paid | 0.7 | 1.28 | 1.52 | 1.37 | 1.79 | 1.6 | 2.49 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 44.3% | Gross profit / revenue. |
| Operating margin | 3.7% | Operating income / revenue. |
| EBITDA margin | 4.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 1.9% | Pre-tax income / revenue. |
| Net margin | 1.8% | Net income / revenue. |
| FCF margin | 0.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 0.9% | Cash from operations / revenue. |
| Effective tax rate | 14.6% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | 5.8% | Net income / average total assets. |
| R&D / revenue | 8.7% | Research and development expense / revenue. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.4% | Capital expenditures / revenue. |
| D&A / revenue | 0.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 9.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 5.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 11.7% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -0.6% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -0.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 10.9% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 55.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | 43.7% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | 36.3% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | 30.0% | EPS vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | 13.6% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -5.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -2.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 1.4% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -1.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 1.2% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.59x | Current assets / current liabilities. |
| Quick ratio | 0.38x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.25x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 197.9% | Total liabilities / total assets. |
| Interest coverage | 3.51x | Operating income / interest expense. |
| Working capital | -$173.4M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 5.6% | (Goodwill + intangible assets) / total assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 3.18x | Revenue / average total assets. |
| Inventory turnover | 21.4x | Cost of revenue / average inventory. |
| Days inventory | 17 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 15.1x | Revenue / average receivables. |
| Days sales outstanding | 24 days | 365 x average receivables / revenue. |
| Days payables | 14 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 27 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 27.6% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 46.4% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.13 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.13 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $7.05 | Revenue / diluted weighted shares. |
| FCF per share | $0.04 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.07 | Cash from operations / diluted weighted shares. |
| Cash per share | $0.89 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.77B | Share price x shares outstanding. |
| Enterprise value | $1.67B | Market cap + total debt - cash - short-term investments. |
| P/E | 116x | Market cap / net income. Only when net income is positive. |
| P/S | 2.10x | Market cap / revenue. |
| P/FCF | 419x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 225x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.97x | Enterprise value / revenue. |
| EV/EBIT | 52.7x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 47.7x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 394x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 0.2% | Free cash flow / market cap. |
| Earnings yield | 0.9% | Net income / market cap (the inverse of P/E). |
What was Youdao, Inc.'s revenue in fiscal 2025?
Youdao, Inc. reported revenue of $845.0M for fiscal 2025, 9.6% higher than the year before.
Was Youdao, Inc. profitable in fiscal 2025?
Yes. Net income was $15.4M, a net margin of 1.8%.
How much free cash flow did Youdao, Inc. generate in fiscal 2025?
Cash from operations of $7.9M minus capital expenditures of $3.7M left free cash flow of $4.2M.